Founded

Address

S*Bio Pte Ltd
Singapore

Open map

KANDO id: 377700

Corporate information

Registration country

Company type

Singapore-based cancer therapeutics company which, focuses on the discovery, research, and clinical development of small molecule drugs.

Funding rounds

Venture USD 5,000,000


USD 5,000,000 ( )

Profile Country
Mitsui & Co Global Investment Inc (三井グループ)

Other USD 112,500,000


USD 112,500,000 ( )
Global exclusive license to develop and commercialize multi-kinase inhibitor SB1317.

Profile Country Notes
Tragara Pharmaceuticals Inc Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. USD 112,500,000 (USD 112,500,000)

Series B USD 26,000,000


USD 26,000,000 ( )

Profile Country Notes
Aravis Venture Associates AG (Aravis Ventures) Led the round. (Co-led the investment round.)
Bio*One Capital Pte Ltd (USD 60,000,000) (Co-led the investment round. Repeat investment.)
Lacuna LLC
ZKB Start-up Finance (Repeat investment.)

Profile Country
Novartis Services Inc (Novartis Venture Fund)


Investment activity status
Not investing

Current team

Past employees

Selected Products / Customers

Financials